Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

Cell Culture Market - Global Size, Share, Trends, and Forecast 2026-2032 | USD 80.23 Billion Opportunity Fueled by Biologics, Cell Therapies, AI, and Single-Use Systems

globenewswire.com
BDX BIIB BKR CHTR CL CMCSA COR CSCO DHR DIS EMR GOOG IBM INTC JNJ LLY META MRK MSFT MU NFLX NVDA ORCL PAYX PEP PFE QCOM ROKU SMCI SNOW TCOM TEAM TECK TMUS TSLA TXN VRTX WDC XOM AMD AMZN AVTR BIO BMY CAT CHKP CTAS CTSH DELL DOV EA EBAY EXC FAST FDX FIS FISV GILD GOOGL HON HSIC IDXX ILMN INTU ISRG JD KDP KHC KLAC LRCX LULU MAR MCHP MDLZ MELI MNST MO MRVL NTAP NXPI ORLY PCAR PDD PGR PHG PLTR PNW PPG PTON PRGS PSA RCL REGN ROST RYAAY SBUX SIRI SNPS SO SWKS SYK T TEL TER TGT TMO ULTA UPS VRSK VTR WEC WFC WMB XRAY ZBRA ZION ZTS

United States Personalized Medicine Market - Genomic Trends, Size, Share, and Forecast 2026-2034 | AI, NGS, and Targeted Therapies Propel Growth to US$327.97 Billion

globenewswire.com
ABT GEHC ILMN QGEN LLY TAK ABBV

Denmark Pharmaceutical Market - Size, Share, Drug Development, Competitive Analysis, and Forecast 2026-2034 | Biologics and Personalized Medicine Drive Growth to US$5.38 Billion

globenewswire.com
NVO UCB LLY

Lilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitis

prnewswire.com
LLY

Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

prnewswire.com
LLY

Health Care and Crude Led the Week While Tech Lost Its Grip

prnewswire.com
MA V UNH HUM ELV ABT ISRG MDT LLY JNJ ABBV MRK

Global Alpha-Emitting Radioligand Therapy Market Size, Share, Trends, and Forecast to 2035 | USD 3.01 Billion Opportunity Driven by Precision Oncology and Isotope Expansion

globenewswire.com
AZN BMY LLY NVS ACIU TLX

Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery

globenewswire.com
ILMN DHR BDX BIO BRKR QGEN XRAY EXAS TMO ABT AMGN AGNC AMZN GOOG QNRX NVDA IBM MRNA PFE JNJ BMY GILD AMAT ASML LRCX KLAC MU AMD INTC SNOW CRSP EDIT BEAM REGN VRTX BIIB LLY ACN MSFT XOM CVX

Global Biomarker-Driven Drug Development Market - Strategic Insights and Forecasts, 2026-2031 | Precision Medicine and Multi-Omics Drive 10.2% CAGR to USD 35.9 Billion

globenewswire.com
PFE MRK AMGN LLY GILD

New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year

prnewswire.com
LLY